CLDND1 inhibitors refer to a specialized category of compounds that selectively target and inhibit Claudin Domain Containing 1 (CLDND1), a protein involved in cellular tight junction formation. Tight junctions are integral components of the cellular structure, predominantly in epithelial cells, playing crucial roles in maintaining cell polarity and regulating the paracellular transport of ions and solutes. Inhibitors targeting proteins like CLDND1 that are essential in the formation of tight junctions aim to manipulate and study the biological processes related to cell-cell adhesion, permeability, and barrier functions.
The molecular nature of CLDND1 inhibitors varies, and the class may include an array of compounds ranging from small molecules to peptides and biological toxins. Each inhibitor in this class possesses a unique mechanism of action that may involve direct interaction with the CLDND1 protein or modulation of its expression or function indirectly. For instance, some inhibitors might directly bind to CLDND1, hindering its role in tight junction assembly, while others may influence intracellular pathways that regulate the expression or post-translational modification of CLDND1. This variety in the mechanisms of action enhances the versatility and utility of CLDND1 inhibitors in biological research, allowing for a broader understanding of cellular junction dynamics and the role of CLDND1 in various physiological and cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Fumonisin B1 is a mycotoxin that inhibits CLDN1 expression. This could potentially disrupt the structure and function of tight junctions in various epithelial tissues. | ||||||